- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 08:00 | Paradox Interactive AB (publ): Interim report January - March 2026 | 101 | FIRST QUARTER
Revenues amounted to MSEK 431.1 (MSEK 463.6), a decrease of 7% compared to the same period last year.
Operating profit amounted to MSEK 100.8 (MSEK 146.6), a decrease of 31%.
Profit... ► Artikel lesen | ||
| 08:00 | Wall To Wall Group AB: Wall To Wall Group Interim Report Q1 2026 | 50 | Seasonally slow start with clearly stronger activity towards the end of the quarterImproved results driven by lower costs and improved marginsImproved profitability expected as volume increasesSUMMARY... ► Artikel lesen | ||
| 08:00 | Dicot Pharma AB: Dicot Pharma presents interim report Q1 2026 and invites to a webcast | 49 | Uppsala, Sweden, April 30, 2026. Dicot Pharma AB publishes its interim report for the first quarter of 2026. The report is available as an attached document and on www.dicotpharma.com. The company will... ► Artikel lesen | ||
| 08:00 | Hexagon AB: Hexagon releases new targets at its Capital Markets Day 2026 | 96 | Hexagon is the global leader in precision measurement, positioning and autonomous solutions with a serviceable addressable market of ~€38bn by 2030.
Hexagon's €3.7bn in revenue and ~17,000 employees... ► Artikel lesen | ||
| 08:00 | International Personal Finance plc.: Q1 2026 Trading Update | 610 | 30 April 2026
International Personal Finance plc
Q1 2026 trading update
A positive start to 2026
International Personal Finance plc ("IPF" or the "Group") is helping to build a better world through... ► Artikel lesen | ||
| 08:00 | AlzeCure Pharma AB: Adjusted timeline for the previously communicated rights issue | 69 | AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, announces that the timeline... ► Artikel lesen | ||
| 08:00 | Xbrane Biopharma AB: Xbrane Submits Ranibizumab Biosimilar Candidate To FDA | 362 | Xbrane Biopharma AB (Nasdaq Stockholm: XBRANE) has submitted an application for approval (BLA) to the U.S. Food and Drug Administration for its biosimilar candidate to LUCENTIS (ranibizumab).
The original... ► Artikel lesen | ||
| 08:00 | Viaplay Group AB: Viaplay Group to show UEFA Club competitions in Denmark, Norway and Finland until 2031 | 240 | Viaplay Group has extended its exclusive rights to men's UEFA Champions League football in Denmark, and the exclusive rights to the UEFA Europa League and UEFA Conference League in Norway and Finland... ► Artikel lesen | ||
| 08:00 | Amaroq Ltd.: Amaroq Doubles Revolving Credit Facility to US$70 Million | 96 | Reykjavík, April 30, 2026 (GLOBE NEWSWIRE) -- Amaroq Ltd.("Amaroq" or the "Company") Amaroq Doubles Revolving Credit Facility to US$70 Million Upsized $70 million Revolving Credit Facility Agreement... ► Artikel lesen | ||
| 08:00 | Integrum AB: Integrum implements a write-down of approximately SEK 7 million following reclassification of certain inventory items | 231 | Mölndal, Sweden, April 30, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that, as part of preparing the annual financial statements for the 2025/2026 fiscal year... ► Artikel lesen | ||
| 07:46 | NICOX SA: Nicox Provides Full Year 2025 Financial Results and Corporate Update | 388 | Press Release Nicox Provides Full Year 2025 Financial Results and Corporate Update
Revenue of €16.8 million (€7.9 million in 2024) Net loss significantly reduced to €2.4 million (€22.4 million... ► Artikel lesen | ||
| 07:36 | 74Software: Double-digit Organic Growth in Q1 2026, with Further Progress Toward Recurring Software Revenue | 71 | Press Release 74Software: Double-digit Organic Growth in Q1 2026, with Further Progress Toward Recurring Software Revenue Paris, April 30, 2026 - 74Software (Euronext Paris: 74SW) reported Q1 2026... ► Artikel lesen | ||
| 07:36 | Inbank unaudited financial results for Q1 2026 | 178 | Inbank started 2026 with strong sales growth and stable underlying performance, while profitability development was more moderate. In Q1 2026 Inbank earned a consolidated net profit of €4 million... ► Artikel lesen | ||
| 07:36 | INVL Technology Interim information for 3 months of 2026 | 68 | Equity of INVL Technology and the Company's net asset value as of 31 March 2026 was EUR 65.5 million or EUR 5.4708 per share (31 December 2025 these figures were EUR 64.62 million and EUR 5.4013 respectively).... ► Artikel lesen | ||
| 07:36 | Ayvens: Strong Q1 2026 financial results, on track to achieve PowerUP 2026 targets | 136 | NET INCOME GROUP SHARE OF EUR 266 MILLION, UP 21.2% VS. Q1 2025 RETURN ON TANGIBLE EQUITY (ROTE) AT 13.9% VS. 11.0% IN Q1 2025EPS1 AT EUR 0.31 UP 29% VS. Q1 2025 Q1 2026 RESULTS2 Leasing and Services... ► Artikel lesen | ||
| 07:36 | OSE Immunotherapeutics Reports Full Year 2025 Unaudited Consolidated Financial Results and 2026 Q1 Cash Position | 99 | OSE entered 2026 with a clear 3-year strategic roadmap focused on delivering multiple catalysts for both lusvertikimab and Tedopi®1€22.7 and €17.0 million cash position as of December 31, 2025, and... ► Artikel lesen | ||
| 07:36 | Danske Bank A/S: Danske Bank announces financial targets for 2028 and an updated capital framework | 97 | Danske Bank announces financial targets for 2028 and an updated capital framework Danske Bank today announces an update to its Forward '28 strategy, including financial targets for 2028, a revised dividend... ► Artikel lesen | ||
| 07:36 | Realkredit Danmark A/S: Company announcement for the first quarter of 2026 | 71 | Company announcement number 35/2026 30 April 2026 Company announcement... ► Artikel lesen | ||
| 07:36 | Danske Bank A/S: Solid financial performance in the first quarter of 2026 driven by good customer activity, lending growth and strong credit quality Net profit of DKK 5.7 billion | 86 | Solid financial performance in the first quarter of 2026 driven by good customer activity, lending growth and strong credit qualityNet profit of DKK 5.7 billion Carsten Egeriis, Chief Executive Officer... ► Artikel lesen | ||
| 07:30 | Q-Linea AB: Interim report January - March 2026 | 145 | Growing recurring income and increased market activity within rapid AST
First quarter: 1 January-31 March 2026Income from sales of consumables amounted to SEK 1.4 (0.9) million, an increase of approx.... ► Artikel lesen | ||
| 07:18 | Valneva Announces the Successful Completion of an €84 million Reserved Offering | 304 | Valneva Announces the Successful Completion of an €84 million Reserved Offering Lyon (France), April 30, 2026 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) ("Valneva" or the "Company"), a specialty... ► Artikel lesen | ||
| 07:10 | Santhera Pharmaceuticals Holding AG: Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors | 251 | Ad hoc announcement pursuant to Art. 53 LR.
Pratteln, Switzerland, April 30, 2026 - Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director... ► Artikel lesen | ||
| 07:10 | F. Hoffmann-La Roche Ltd: Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026 | 336 | New real-world data confirm Vabysmo's potent retinal drying in nAMD and DMEKey data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing... ► Artikel lesen | ||
| 07:10 | IMCD N.V.: IMCD reports EBITA of EUR 130 million in the first three months of 2026 | 265 | Rotterdam, The Netherlands (30 April 2026) - IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its... ► Artikel lesen | ||
| 07:10 | ING Group: ING completes share buyback and announces new programme of up to €1.0 billion | 300 | ING completes share buyback and announces new programme of up to €1.0 billion
ING announced today that it has completed the share buyback programme announced on 30 October 2025. The total number... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.